Kim Byung-Jang – CEO, Mega Medical – South Korea
The CEO of Mega Medical, a Korean medical equipment manufacturer specialized in the ENT area, discusses his firm’s recent expansion into the anti-obesity segment, their strategy for building a global…
Since its establishment in 1995, Mega medical Co., Ltd. has localized medical equipment for ear-note-and throat (ENT), and currently been ranked No. 1 in domestic market share. This company will make every effort not only to maintain No. 1 market share in domestic market but also to take the first position in overseas markets.
1997 Specialized ENT unit launch
1999 Patent acquisition for wall-type nebulizer
2005 Cell-Q, a new obesity treatment product development
2006 Wireless visual system is selected as (wireless visual system) the world best quality product
2007 Digital wireless visual system development
2008 Obesity treatment device solution, Nato irrigation development
2009 HD visual system Development
2010 technical development for ENT Microscope development
2011 LIPO carbon therapy development
2013 Obesity treatment complex device development
Through consistent overseas market development since the establishment, Mega medical Co., Ltd. have exported out products over 40 countries including Europe, Asia, China, and Middle-East, and worked for global network construction.
Contact Details
Domestic inquiries
domestic@megamedical.co.kr
Tel. 1588-4493 (02-3662-4493)
Fax. 02-3661-0120
For overseas clients
Inquiry about products and warranty
webmaster@megamedical.co.kr
Tel. +82-2-3662-4493
Fax. +82-2-3661-0120
Address
#2504, 2505, A Bldg, Woolim blue 9 Business Center, 583, Yangcheon-ro, Gangseo-gu, Seoul (ZIP 157-779)
The CEO of Mega Medical, a Korean medical equipment manufacturer specialized in the ENT area, discusses his firm’s recent expansion into the anti-obesity segment, their strategy for building a global…
South Korea has carved a place for itself as a dominant player in the global pharma and med-tech manufacturing industry with national companies Samsung Biologics and Celltrion leading the way.…
After a dynamic two years as CEO of Samsung Biologics, John Rim highlights some of the fundamentals behind the company’s rapid growth as a CDMO, including the creation of huge…
Stephen Yoo highlights the pioneering work that STCube Pharmaceuticals – a US subsidiary of Korean firm STCube – is undertaking in the immuno-oncology field, its three technology platforms, partnership approach,…
Founder and CEO of GeneMedicine, Dr Chae-Ok Yun, explains how the company, specialised in oncolytic virus development, has progressed since we last interviewed her two years ago, with one of…
Eutilex’s CEO, Byoung S. Kwon, outlines the company’s approach to cancer research, including its antibodies and CAR-T-centred pipeline and focus on unmet needs. He also explains recent partnerships in China.…
The latest healthcare and pharma news from South Korea, including SK Bioscience’s COVID-19 vaccine, Daewoong’s partnership with AstraZeneca Korea and UCI Therapeutics, Vivozon production halt and GC’s acquistion of US-based…
Chair & Founder, Regenerative Medicine Acceleration Foundation (RMAF), So Ra Park MD, PhD*, comments on the regenerative medicine ecosystem in Korea, the country’s new legislative approach to the field, and…
KHIDI’s Soonman KWON outlines the public health R&D funding landscape in Korea, plans to increase Korea’s capacity to develop and produce its own vaccines in the wake of the COVID-19…
Two decades ago, South Korean company Celltrion embarked on a quest to find the necessary resources to produce biopharmaceuticals. It took five years for their manufacturing plant to receive GMP…
Boasting a pharma market size of KRW 23.2 trillion (USD 19.2 billion) for 2020, South Korea is one of Asia’s leading pharma nations. Read on for a ranking of the…
Amid global supply shortages and shipment delays for COVID-19 vaccines, South Korea has launched an ambitious 2.2 trillion won (USD 1.9 billion) investment plan to become one of the world’s…
Francis Van Parys, vice president commercial Asia-Pacific at Cytiva, a global life sciences leader dedicated to advancing and accelerating therapeutics, highlights the firm’s tireless work to meet the exponential demand…
See our Cookie Privacy Policy Here
